230 related articles for article (PubMed ID: 26481002)
1. Bisphosphonate-Related Osteonecrosis of the Jaw in an 80-Year-Old Woman with Diabetes Mellitus: Case Report.
Valenzuela L; Alonso-Bouzón C; Mañas LR
J Am Geriatr Soc; 2015 Oct; 63(10):2221-2. PubMed ID: 26481002
[No Abstract] [Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
[No Abstract] [Full Text] [Related]
3. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
Gómez-Moreno G; Arribas-Fernández MC; Fernández-Guerrero M; Boquete-Castro A; Aguilar-Salvatierra A; Guardia J; Botticelli D; Calvo-Guirado JL
Eur Rev Med Pharmacol Sci; 2014; 18(9):1391-7. PubMed ID: 24867519
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
Wynn RL
Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
[No Abstract] [Full Text] [Related]
6. Osteonecrosis related to once-yearly zoledronic acid treatment in an osteoporotic patient after dental implant.
Miniello TG; Araújo JP; Lopes RN; Alves FA
Braz Dent J; 2015; 26(1):86-8. PubMed ID: 25672391
[TBL] [Abstract][Full Text] [Related]
7. A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
[No Abstract] [Full Text] [Related]
8. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
[No Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
[TBL] [Abstract][Full Text] [Related]
10. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
11. Risk Factors in the Development of Oral Bisphosphonate-induced Osteonecrosis.
Reiss S; Sultan D
N Y State Dent J; 2015 Nov; 81(6):30-3. PubMed ID: 26749781
[TBL] [Abstract][Full Text] [Related]
12. Avascular necrosis of the proximal carpal row of the wrist. A possible complication of bisphosphonate administration.
Didden K; De Smet L; Vandenberghe L; Sciot R; Degreef I
Chir Main; 2012 Dec; 31(6):355-7. PubMed ID: 23177907
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaw.
Sari E; Bulut N; Altundag K
J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
[No Abstract] [Full Text] [Related]
14. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Sánchez A; Blanco R
Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
[TBL] [Abstract][Full Text] [Related]
15. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.
Bantis A; Zissimopoulos A; Sountoulides P; Kalaitzis C; Giannakopoulos S; Deftereos S; Tsakaldimis G; Thomaidis V; Touloupidis S
Tumori; 2011; 97(4):479-83. PubMed ID: 21989437
[TBL] [Abstract][Full Text] [Related]
18. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Soós B; Vajta L; Szalma J
Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis drugs linked to jawbone destruction.
J Calif Dent Assoc; 2014 Jul; 42(7):435. PubMed ID: 25076619
[No Abstract] [Full Text] [Related]
20. Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report.
Pan WL; Chen PL; Lin CY; Pan YC; Ju YR; Chan CP; Hsu RW
Clin Interv Aging; 2017; 12():1089-1093. PubMed ID: 28744112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]